Intravenous nesiritide (human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure

Am J Cardiol. 2002 Aug 15;90(4):435-8. doi: 10.1016/s0002-9149(02)02507-9.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Endothelin-1 / blood*
  • Female
  • Heart Failure / blood*
  • Heart Failure / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Natriuretic Agents / pharmacology
  • Natriuretic Agents / therapeutic use*
  • Natriuretic Peptide, Brain
  • Statistics as Topic

Substances

  • Endothelin-1
  • Natriuretic Agents
  • Natriuretic Peptide, Brain